Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.6 USD | +0.24% | +5.80% | +0.25% |
Chart calendar Agenus Inc.
Upcoming events on Agenus Inc.
Past events on Agenus Inc.
2024-06-01 02:30 pm | American Society of Clinical Oncology Meeting - Abstract No: 3556 |
2024-05-07 08:30 am | Q1 2024 Earnings Call |
2024-05-07 07:40 am | Q1 2024 Earnings Release |
2024-04-11 | Reverse Split: 1 of 20 |
2024-04-08 05:30 pm | American Association for Cancer Research Meeting - Abstract Number: 3915 |
2024-04-03 10:00 am | Extraordinary Shareholders Meeting |
2024-03-14 08:30 am | Q4 2023 Earnings Call |
2024-03-14 07:30 am | Q4 2023 Earnings Release |
2024-03-11 02:40 pm | Leerink Partners Global Biopharma Conference |
2024-02-14 08:00 am | Oppenheimer Healthcare Life Sciences Conference - Fireside Chat |
2024-01-20 06:30 am | ASCO-GI Meeting |
2024-01-18 03:00 pm | B. Riley Securities Oncology Conference |
2023-11-07 09:00 am | Q3 2023 Earnings Call |
2023-11-07 06:30 am | Q3 2023 Earnings Release |
2023-10-22 01:00 pm | European Society for Medical Oncology Congress |
2023-10-21 04:15 pm | European Society for Medical Oncology Congress - Abstract No:1919MO |
2023-10-17 | Investor Meeting |
2023-09-13 11:00 am | H.C. Wainwright Global Investment Conference |
2023-09-12 04:20 pm | Baird Global Healthcare Conference |
2023-09-07 11:00 am | Wells Fargo Healthcare Conference |
Past dividends on Agenus Inc.
2023-04-25 | 0 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 150 129 16.72% | 88,2 74,6 18.19% | 296 313 -5.58% | 98,0 82,5 18.79% | 156 119 31.42% | 206 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -154 -146 -5.51% | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -70,1 -101 30.85% | -115 -122 5.92% | 25,7 59,6 -56.81% | -179 -174 -2.9% | -160 -160 0.55% | -64,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -112 -131 15.03% | -183 -187 2.41% | -28,7 -0,30 -9474.67% | -231 -231 -0.04% | -257 -218 -18.27% | -161 |
Net income Million USD | Released Forecast Spread | -112 -133 15.99% | -183 -186 1.72% | -24,1 6,25 -486.28% | -231 -221 -4.51% | -257 -225 -14.64% | -185 |
EPS USD | Released Forecast Spread | -16,0 -20,7 22.83% | -21,0 -21,5 2.17% | -2,20 -0,75 -193.33% | -15,6 -15,5 -0.86% | -13,8 -12,5 -10.4% | -8,92 |
Announcement Date | 12/03/20 | 15/03/21 | 01/03/22 | 14/03/23 | 14/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 25,9 15,7 64.87% | 20,9 18,7 11.93% | 22,8 20,7 10.05% | 28,4 17,8 59.24% | 22,9 23,5 -2.69% | 25,3 24,1 4.82% | 24,3 25,2 -3.38% | 83,8 47,1 78.09% | 28,0 47,2 -40.63% | 57,3 | 62,3 | 56,8 | ||
EBIT Million USD | Released Forecast Spread | -35,5 -62,1 42.93% | -44,6 -43,7 -1.93% | -41,6 -38,4 -8.54% | -57,8 -47,9 -20.57% | -54,3 -49,6 -9.45% | -54,7 -48,7 -12.35% | -46,3 -55,4 16.39% | -4,20 -4,55 7.57% | -32,9 -36,6 10.07% | -17,5 | -16,9 | -13,6 | ||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -50,6 -76,6 33.97% | -49,2 -61,1 19.42% | -56,7 -51,2 -10.84% | -74,1 -68,7 -7.92% | -70,9 -69,5 -2.08% | -73,4 -64,0 -14.68% | -64,5 -73,0 11.66% | -48,6 -10,1 -379.38% | -63,5 -53,8 -17.85% | -37,6 | -35,9 | -28,1 | ||
Net income Million USD | Released Forecast Spread | -48,4 -76,2 36.48% | -49,2 -59,1 16.76% | -54,3 -51,8 -4.86% | -74,1 -64,0 -15.79% | -70,9 -64,9 -9.29% | -73,4 -64,6 -13.58% | -64,5 -72,5 10.93% | -48,6 -49,0 0.8% | -61,9 -62,6 1.08% | -43,4 | -42,7 | -38,2 | ||
EPS USD | Released Forecast Spread | -3,80 -5,95 36.13% | -3,40 -4,60 26.09% | -3,80 -3,75 -1.33% | -4,80 -4,37 -9.92% | -4,40 -4,20 -4.76% | -4,00 -3,97 -0.84% | -3,20 -3,95 18.99% | -2,60 -1,05 -147.62% | -3,04 -3,22 5.47% | -1,64 | -1,51 | -2,10 | -3,20 | -3,36 |
Announcement Date | 10/05/22 | 09/08/22 | 08/11/22 | 14/03/23 | 09/05/23 | 08/08/23 | 07/11/23 | 14/03/24 | 07/05/24 | - | - | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Agenus Inc.
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AGEN Stock
- Calendar Agenus Inc.